Compare · HCAT vs NBIS
HCAT vs NBIS
Side-by-side comparison of Health Catalyst Inc (HCAT) and Nebius Group N.V. (NBIS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HCAT and NBIS operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- NBIS is the larger of the two at $60.34B, about 507.5x HCAT ($118.9M).
- NBIS has been more active in the news (20 items in the past 4 weeks vs 5 for HCAT).
- HCAT has more recent analyst coverage (25 ratings vs 18 for NBIS).
- Company
- Health Catalyst Inc
- Nebius Group N.V.
- Price
- $1.58-0.94%
- $222.01+5.36%
- Market cap
- $118.9M
- $60.34B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- 2011
- News (4w)
- 5
- 20
- Recent ratings
- 25
- 18
HCAT
Health Catalyst Inc
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions include a cloud-based data platform, analytics software, and professional services. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. The company was founded in 2008 and is headquartered in South Jordan, Utah.
Latest HCAT
- Health Catalyst downgraded by Canaccord Genuity with a new price target
- SEC Form 10-Q filed by Health Catalyst Inc
- Health Catalyst Inc filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company
- Health Catalyst Reports Second Quarter 2026 Results
- Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026
- Director Hoggard Green Jill was granted 80,691 shares, increasing direct ownership by 126% to 144,628 units (SEC Form 4)
- Director Larson-Green Julie was granted 80,691 shares, increasing direct ownership by 85% to 175,335 units (SEC Form 4)
- Director Nelson Steven H was granted 80,691 shares, increasing direct ownership by 52% to 235,499 units (SEC Form 4)
- Director Spencer Justin was granted 80,691 shares, increasing direct ownership by 118% to 149,263 units (SEC Form 4)
Latest NBIS
- SEC Form 6-K filed by Nebius Group N.V.
- Nebius Group N.V. announces results of its Annual General Meeting
- SEC Form 6-K filed by Nebius Group N.V.
- Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $5.75 billion
- SEC Form 6-K filed by Nebius Group N.V.
- Nebius Group announces pricing of upsized private offering of $5.0 billion of convertible senior notes
- SEC Form 6-K filed by Nebius Group N.V.
- Nebius Group announces proposed private offering of $4.50 billion of convertible senior notes
- Director Ryan Charles E sold $13,276,633 worth of Class A Shares (50,000 units at $265.53), decreasing direct ownership by 16% to 272,533 units (SEC Form 4)
- Director Boynton John Wilson Iv sold $1,435,147 worth of Class A Shares (5,296 units at $270.99), decreasing direct ownership by 1% to 415,844 units (SEC Form 4)